Rabeprazole: a pharmacologic and clinical review for acid-related disorders (Q56431955)

Expert Opinion on Drug Safety

Europe PubMed Central

title

Rabeprazole: a pharmacologic and clinical review for acid-related disorders (English)

0 references

1 reference

Alia Dadabhai

1

0 references

Frank K Friedenberg

series ordinal

2

0 references

language of work or name

English

0 references

publication date

January 2009

0 references

published in

0 references

volume

8

0 references

issue

1

0 references

page(s)

119-126

0 references

cites work

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Review article: the pharmacokinetics of rabeprazole in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Review article: rabeprazole's tolerability profile in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Gastroesophageal reflux disease and asthma: the two are directly related

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

The safety of proton pump inhibitors in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892

Seven-day therapy for Helicobacter pylori in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330802622892